Form 4: Cargo Therapeutics' Chief Medical Officer, Ginna Laport, Acquires 100,000 Stock Options
SEC Filing
Ginna Laport, Chief Medical Officer of Cargo Therapeutics, acquired 100,000 stock options on March 1, 2024, as reported in a Form 4 filing with the SEC.
Summary
- Ginna Laport, the Chief Medical Officer of Cargo Therapeutics, Inc. (CRGX), filed a Form 4 with the SEC.
- The filing reports that on March 1, 2024, Laport acquired 100,000 stock options with an exercise price of $25.07.
- These options vest monthly, with 1/48th of the shares vesting each month starting from January 1, 2024, and will be fully vested by the fourth anniversary of that date (February 28, 2034).
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a routine disclosure of stock option grants to a company executive.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Stakeholder Impact
- The granting of stock options aligns the interests of the Chief Medical Officer with those of the shareholders, incentivizing her to contribute to the company's success.
Key Dates
| Date | Description |
|---|---|
| 01/01/2024 | Vesting Commencement Date for the stock options. |
| 03/01/2024 | Date of transaction: Ginna Laport acquired 100,000 stock options. |
| 03/04/2024 | Date of Form 4 filing. |
| 02/28/2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.